9-133208553-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014581.4(OBP2B):c.122C>T(p.Pro41Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,460,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P41R) has been classified as Uncertain significance.
Frequency
Consequence
NM_014581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OBP2B | NM_014581.4 | c.122C>T | p.Pro41Leu | missense_variant | 2/7 | ENST00000372034.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OBP2B | ENST00000372034.8 | c.122C>T | p.Pro41Leu | missense_variant | 2/7 | 1 | NM_014581.4 | P1 | |
OBP2B | ENST00000618116.4 | c.122C>T | p.Pro41Leu | missense_variant | 2/7 | 1 | P1 | ||
OBP2B | ENST00000473737.5 | c.122C>T | p.Pro41Leu | missense_variant, NMD_transcript_variant | 2/8 | 1 | |||
OBP2B | ENST00000461961.2 | n.115-350C>T | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000407 AC: 1AN: 245932Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 132954
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1460824Hom.: 0 Cov.: 35 AF XY: 0.0000110 AC XY: 8AN XY: 726654
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2024 | The c.122C>T (p.P41L) alteration is located in exon 2 (coding exon 2) of the OBP2B gene. This alteration results from a C to T substitution at nucleotide position 122, causing the proline (P) at amino acid position 41 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at